In this article we will explore the topic of COVID-19 vaccination in Algeria from a multidisciplinary perspective, addressing its historical, social and cultural implications. _Var1 is a topic that has aroused the interest of researchers and experts in various fields, and its relevance is evident in the contemporary context. Throughout the article, we will examine different approaches and theories related to COVID-19 vaccination in Algeria, as well as its impact on today's society. Through detailed analysis, we aim to offer a comprehensive view of COVID-19 vaccination in Algeria, exposing its lesser-known facets and highlighting its importance in the current landscape.
Date | 29 January 2021 |
---|---|
Location | vaccination clinics |
Cause | COVID-19 pandemic |
Participants | 2,500,000 doses administered Sputnik V and Oxford-AstraZeneca (6 June 2021) 2,500,000 Total vaccinated people (to which the first and second dose of vaccine were administered) |
Footage | https://corona-dz.live/ |
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.
Algeria has reported on administering over 2.5 million doses of the vaccine. Data is only reported every few weeks or months apart without secondary dose information.
On 28 January 2021, Algeria received 50,000 doses of Russia's Sputnik V vaccine which landed at Algiers International Airport.
On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of Russia's Sputnik V vaccine.
On 1 February, 50,000 doses of the Oxford–AstraZeneca COVID-19 vaccine arrived.
On 25 February 2021, Algeria received 200,000 more vaccines from China.
364,800 doses of the Oxford-AstraZeneca vaccine were delivered on 3 April through the COVAX pillar.
On 7 April, minister Lotfi Benbahmad announced that an agreement had been reached to produce Sputnik V at Saidal's manufacturing plant in Constantine.
On 26 April, the U.S. provided more than 600,000 doses of the Johnson & Johnson COVID-19 vaccine.
By the end of the month, 4.1 million vaccine doses had been administered.
By the end of the month, 10.2 million vaccine doses had been administered.
By the end of the month, 11.2 million vaccine doses had been administered while 27% of the target population had been fully vaccinated.
By the end of the month, 12.1 million vaccine doses had been administered while 30% of the target population had been fully vaccinated.
By the end of the month, 12.5 million vaccine doses had been administered while 31% of the target population had been fully vaccinated.
By the end of the month, 13 million vaccine doses had been administered while 32% of the target population had been fully vaccinated.
By the end of the month, 15 million vaccine doses had been administered while 6.5 million persons had been fully vaccinated.
Cumulative vaccinations in Algeria
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |
Daily vaccinations chart of Algeria
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |